The above chart presents the market trend analysis for novo nordisk farmaceutica ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 59 transactions, with a transaction quantity of 57065.86 and a transaction weight of 408647.82.
YearTransactionsQuantityWeight
2025238413202.491254658.37
20265957065.86408647.82
Bill of lading data
<
1/15
>
Trade date
2026/06/03
B/L No.
dmalanrb66527
Suppliers
novo nordisk mexico
Buyers
novo nordisk farmaceutica ltd.
Product description
LABELLING MACHINE ORDER NO; L,, DELIVERY NOTE NO. , INVOICE NO. PO NO. S/ Expand
Trade date
2026/04/24
B/L No.
aclusa01261372
Suppliers
ohly gmbh
Buyers
novo nordisk farmaceutica ltd.
POLs
42879, stadersand
PODs
1401, norfolk, va
Supply area
Germany
Purchas area
United States
Weight
63480kg
Amount
465280
Hs code
847150
Product tags
non haz,yeast,seed,cod,extract liquid,carbon,neu
Product description
YEAST EXTRACT LIQUID X-SEED KAF CARBON NEUTRAL NON HAZARDOUS HS CODE PO YEAST EXTRACT LIQUID X-SEED KAF CARBON NEUTRAL NON HAZARDOUS HS CODE PO CONTAINERS SAID TO CONTAIN CONTAINERS SAID TO CONTAIN CONTAINERS SAID TO CONTAIN YEAST EXTRACT LIQUID X-SEED KAF CARBON NEUTRAL NON HAZARDOUS HS CODE PO Expand
Trade date
2026/04/14
B/L No.
673732
Suppliers
eskayef pharmaceuticals ltd.
Buyers
novo nordisk farmaceutica ltd.
4citra
belgiumbuyer,they trade on 2019-07-29
831.38%
>
5citra s.c.
italysupplier,they trade on 2019-07-29
480.80%
>
+View All
Products
Total 76
ProductsTransactionsPerDetail
medicaments of recombinant humna insulin 16334.75%>
oxytocin ampoule 6914.71%>
single preparation containing gonadotrophins 6914.71%>
tablets 6914.71%>
lidocaine 6914.71%>
+View All
Hscode rank
Total 229
HSCode NameTransactionsPerDetail
HS 3004311016334.75%>
HS 300439106914.71%>
HS 40111000398.32%>
HS 40112000214.48%>
HS 90183210183.84%>
+View All
Trading Area
Total 29
AreaTransactionsPerDetail
costa rica73212.17%>
other4807.98%>
germany3726.18%>
denmark2514.17%>
belgium2153.57%>
+View All
Port statistics
Total 35
Port NameTransactionsPerDetail
norfolk88914.78%>
norfolk newport news va81213.50%>
aeropuerto com a merino b69411.54%>
valparaiso61810.27%>
aeropuerto com a m4016.67%>
+View All
novo nordisk farmaceutica ltd. is chile Buyer&Supplier,
and primarily engages in the import and export business of products such as medicaments of recombinant humna insulin,oxytocin ampoule,single preparation containing gonadotrophins.
According to the 52wmb.com global trade database, as of 2026-06-03, the company has completed 6016 international trades,
with its main trading regions covering costa rica,other,germany etc.
The core products include HS30043110,HS30043910,HS40111000 etc,
often transported via norfolk,port norfolk newport news va, port aeropuerto com a merino b etc,
and its main trading partners are novo nordisk mexico,nipro thailand corp.ltd.таиланд nipro corp.,west pharmaceuticals serv.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on novo nordisk farmaceutica ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.